BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7704543)

  • 1. UV-B modulation of haplo-identical bone marrow cells in the prevention of GVHD and induction of specific transplantation tolerance to intestinal allografts.
    Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
    Transpl Immunol; 1994 Dec; 2(4):331-6. PubMed ID: 7704543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease in rat small bowel transplantation by recipient pretreatment with UV-B-modulated bone marrow cells.
    Chowdhury NC; Jin MX; Oluwole SF
    Transplantation; 1993 Jun; 55(6):1229-35. PubMed ID: 8516807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
    Jin MX; Engelstad K; Oluwole SF
    Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression.
    Ohajekwe OA; Hardy MA; Oluwole SF
    Transplantation; 1995 Dec; 60(12):1510-6. PubMed ID: 8545883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of GVHD by modulation of rat bone marrow with UV-B irradiation: II. Kinetics of migration of UV-B-irradiated bone marrow cells in naive and lethally irradiated rats.
    Oluwole SF; Engelstad K; Hardy MA
    Cell Immunol; 1990 Jun; 128(1):289-300. PubMed ID: 2344623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
    Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
    Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
    Murase N; Ye Q; Nalesnik MA; Demetris AJ; Abu-Elmagd K; Reyes J; Ichikawa N; Okuda T; Fung JJ; Starzl TE
    Transplantation; 2000 Dec; 70(11):1632-41. PubMed ID: 11152226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum.
    Oluwole SF; Engelstad K; James T
    Blood; 1993 Mar; 81(6):1658-65. PubMed ID: 8453111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of allogeneic bone marrow and spleen cell transplantation in a murine model using ultraviolet-B light.
    Pamphilon DH; Alnaqdy AA; Godwin V; Preece AW; Wallington TB
    Blood; 1991 May; 77(9):2072-8. PubMed ID: 1826855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of donor-specific tolerance to rat cardiac and small bowel allografts by intrathymic inoculation of donor T-cells.
    Chowdhury NC; Fawwaz RA; Oluwole SF
    J Surg Res; 1993 Apr; 54(4):368-74. PubMed ID: 8331931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
    Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
    J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft versus host disease in rats made tolerant for organ allografts.
    Morrissey NJ; Blom D; Ryan C; Fisher T; Bronsther O; Orloff M
    J Surg Res; 1997 May; 69(2):307-15. PubMed ID: 9224398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD; Truitt RL
    Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.